What is the recommended course of action for patients with ICH whose INR is elevated because of VKA?
Patients with ICH whose INR is elevated because of VKA should have their VKA withheld, receive therapy to replace vitamin K dependent factors and correct the INR, and receive intravenous vitamin K (Class I; Level of Evidence C).